{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["13"],"submitter":["Nakajima S"],"pubmed_abstract":["<h4>Background and objective</h4>Hypercoagulability is associated with increased risks of ischemic stroke and subsequent mortality in patients with active cancer. This study investigated the relationships between plasma D-dimer levels after stroke treatment and short-term outcomes in patients with cancer-associated stroke.<h4>Methods</h4>This retrospective, observational, multicenter study analyzed consecutive patients with cancer-associated ischemic stroke. Hypercoagulability was assessed by plasma D-dimer levels before and after stroke treatment. Short-term outcomes were assessed in terms of poor outcomes (a modified Rankin Scale score >3), cumulative rates of recurrent ischemic stroke, and mortality at 30 days after admission.<h4>Results</h4>Of 282 patients, 135 (47.9%) showed poor outc"],"journal":["Frontiers in neurology"],"pagination":["868137"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9015657"],"repository":["biostudies-literature"],"pubmed_title":["Post-Treatment Plasma D-Dimer Levels Are Associated With Short-Term Outcomes in Patients With Cancer-Associated Stroke."],"pmcid":["PMC9015657"],"pubmed_authors":["Hira K","Ueno Y","Urabe T","Kawano H","Fujimoto S","Miyamoto N","Nakajima S","Kurita N","Yamashiro K","Kameda T","Hirano T","Tanaka R","Watanabe M","Hattori N"],"additional_accession":[]},"is_claimable":false,"name":"Post-Treatment Plasma D-Dimer Levels Are Associated With Short-Term Outcomes in Patients With Cancer-Associated Stroke.","description":"<h4>Background and objective</h4>Hypercoagulability is associated with increased risks of ischemic stroke and subsequent mortality in patients with active cancer. This study investigated the relationships between plasma D-dimer levels after stroke treatment and short-term outcomes in patients with cancer-associated stroke.<h4>Methods</h4>This retrospective, observational, multicenter study analyzed consecutive patients with cancer-associated ischemic stroke. Hypercoagulability was assessed by plasma D-dimer levels before and after stroke treatment. Short-term outcomes were assessed in terms of poor outcomes (a modified Rankin Scale score >3), cumulative rates of recurrent ischemic stroke, and mortality at 30 days after admission.<h4>Results</h4>Of 282 patients, 135 (47.9%) showed poor outc","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-18T23:02:29.698Z","creation":"2025-04-07T10:46:43.123Z"},"accession":"S-EPMC9015657","cross_references":{"pubmed":["35444612"],"doi":["10.3389/fneur.2022.868137"]}}